Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamide

Cytokine release syndrome (CRS) represents a life‐threatening side effect after haploidentical stem cell transplantation (Haplo‐SCT) with posttransplant cyclophosphamide (PT‐Cy). Factors predictive of CRS development is still a matter of debate. We retrospectively analyzed 102 consecutive patients r...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Med
Glavni autori: Mariotti, Jacopo, Taurino, Daniela, Marino, Fabrizio, Bramanti, Stefania, Sarina, Barbara, Morabito, Lucio, De Philippis, Chiara, Di Vito, Clara, Mavilio, Domenico, Carlo‐Stella, Carmelo, Della Porta, Matteo, Santoro, Armando, Castagna, Luca
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2019
Teme:
Clinical Cancer Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6943086/
https://ncbi.nlm.nih.gov/pubmed/31702882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2607
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items